86 related articles for article (PubMed ID: 8275032)
1. Serum cytokine levels in patients undergoing bone marrow transplantation.
Chasty RC; Lamb WR; Gallati H; Roberts TE; Brenchley PE; Yin JA
Bone Marrow Transplant; 1993 Oct; 12(4):331-6. PubMed ID: 8275032
[TBL] [Abstract][Full Text] [Related]
2. Soluble tumor necrosis factor (sTNF) receptors: a possible prognostic marker for bone marrow transplantation-related complications.
Or R; Kalinkovich A; Nagler A; Weisman Z; Naparstek E; Weiss L; Hahn T
Cytokines Mol Ther; 1996 Dec; 2(4):243-50. PubMed ID: 9384711
[TBL] [Abstract][Full Text] [Related]
3. IL-6 and IL-8 levels in plasma during hematopoietic progenitor transplantation.
Ferrà C; de Sanjosé S; Gallardo D; Berlanga JJ; Rueda F; Marìn D; de la Banda E; Ancìn I; Peris J; Garcìa J; Grañena A
Haematologica; 1998 Dec; 83(12):1082-7. PubMed ID: 9949625
[TBL] [Abstract][Full Text] [Related]
4. Serum cytokine levels in bone marrow transplantation: synergistic interaction of interleukin-6, interferon-gamma, and tumor necrosis factor-alpha in graft-versus-host disease.
Imamura M; Hashino S; Kobayashi H; Kubayashi S; Hirano S; Minagawa T; Tanaka J; Fujii Y; Kobayashi M; Kasai M
Bone Marrow Transplant; 1994 Jun; 13(6):745-51. PubMed ID: 7920309
[TBL] [Abstract][Full Text] [Related]
5. Proinflammatory cytokines and their role in the development of major transplant-related complications in the early phase after allogeneic bone marrow transplantation.
Schots R; Kaufman L; Van Riet I; Ben Othman T; De Waele M; Van Camp B; Demanet C
Leukemia; 2003 Jun; 17(6):1150-6. PubMed ID: 12764383
[TBL] [Abstract][Full Text] [Related]
6. Levels of soluble low affinity IL2 receptors (s-IL2 R) and TNF in the serum after BMT.
Alessandrino EP; Bernasconi P; Colombo A; Boni M; Bonfichi M; Caldera D; Bernasconi C
Bone Marrow Transplant; 1991; 7 Suppl 2():51. PubMed ID: 1878716
[No Abstract] [Full Text] [Related]
7. Serum interleukin-6 levels during bone marrow transplantation: impact on transplant-related toxicity and engraftment.
Steffen M; Dürken M; Pichlmeier U; von dem Busche C; Stockschläder M; Krüger W; Budde-Steffen C; Zander A
Bone Marrow Transplant; 1996 Aug; 18(2):301-7. PubMed ID: 8864438
[TBL] [Abstract][Full Text] [Related]
8. Monitoring of C-reactive protein after allogeneic bone marrow transplantation identifies patients at risk of severe transplant-related complications and mortality.
Schots R; Kaufman L; Van Riet I; Lacor P; Trullemans F; De Waele M; Van Camp B
Bone Marrow Transplant; 1998 Jul; 22(1):79-85. PubMed ID: 9678800
[TBL] [Abstract][Full Text] [Related]
9. Serum concentrations of interleukin-6, tumour necrosis factor-alpha, and C-reactive protein in patients undergoing major operations.
Kragsbjerg P; Holmberg H; Vikerfors T
Eur J Surg; 1995 Jan; 161(1):17-22. PubMed ID: 7727600
[TBL] [Abstract][Full Text] [Related]
10. Increased levels of soluble interleukin-2 receptor in veno-occlusive disease of the liver after allogenic bone marrow transplantation.
Remberger M; Ringdén O
Transplantation; 1995 Dec; 60(11):1293-9. PubMed ID: 8525524
[TBL] [Abstract][Full Text] [Related]
11. Serum interleukin-12 levels in patients undergoing allogeneic or autologous bone marrow transplantation.
Bonnotte B; Burdiles AM; Chehimi J; Carayol G; Pardoux C; Dietrich PY; Kubin M; Blay JY; Caignard A; Ibrahim A; Robinet E; Hayat M; Pico JL; Bourhis JH; Chouaib S
Eur Cytokine Netw; 1996 Sep; 7(3):389-94. PubMed ID: 8954182
[TBL] [Abstract][Full Text] [Related]
12. High interleukin-10 serum levels are associated with fatal outcome in patients after bone marrow transplantation.
Hempel L; Körholz D; Nussbaum P; Bönig H; Burdach S; Zintl F
Bone Marrow Transplant; 1997 Sep; 20(5):365-8. PubMed ID: 9339750
[TBL] [Abstract][Full Text] [Related]
13. Lack of correlation between serum levels and receptor expression of TNF alpha and graft versus host disease following allogeneic bone marrow transplantation.
Robinet E; Pico JL; Ibrahim A; Ostronoff M; Zambon E; Zohar M; Truneh A; Gay F; Hayat M; Chouaib S
Bone Marrow Transplant; 1991; 7 Suppl 2():148. PubMed ID: 1652325
[No Abstract] [Full Text] [Related]
14. Relationship of serum levels of interleukin-6, soluble interleukin-6 receptor and tumour necrosis factor receptors to the acute-phase protein response in advanced pancreatic cancer.
Barber MD; Fearon KC; Ross JA
Clin Sci (Lond); 1999 Jan; 96(1):83-7. PubMed ID: 9857110
[TBL] [Abstract][Full Text] [Related]
15. Serial measurements of interleukin-6, interleukin-8, tumor necrosis factor-alpha, and soluble vascular cell adhesion molecule-1 in the peripheral blood plasma of human cardiac allograft recipients.
George JF; Kirklin JK; Naftel DC; Bourge RC; White-Williams C; McGiffin DC; Savunen T; Everson MP
J Heart Lung Transplant; 1997 Oct; 16(10):1046-53. PubMed ID: 9361247
[TBL] [Abstract][Full Text] [Related]
16. Time course of interferon-gamma production deficiency after autologous and allogeneic stem cell transplantation for malignancies.
Hanenberg H; Dilloo D; Laws HJ; Zessack N; Heyll A; Burdach S
Exp Hematol; 1995 Dec; 23(14):1543-52. PubMed ID: 8542945
[TBL] [Abstract][Full Text] [Related]
17. The kinetics of circulating cytokines including IL-6, TNF-alpha, IL-8 and IL-10 following allogeneic hematopoietic stem cell transplantation.
Min CK; Lee WY; Min DJ; Lee DG; Kim YJ; Park YH; Kim HJ; Lee S; Kim DW; Lee JW; Min WS; Kim CC
Bone Marrow Transplant; 2001 Nov; 28(10):935-40. PubMed ID: 11753547
[TBL] [Abstract][Full Text] [Related]
18. Systemic levels of the T cell regulatory cytokines IL-10 and IL-12 in Bechçet's disease; soluble TNFR-75 as a biological marker of disease activity.
Turan B; Gallati H; Erdi H; Gürler A; Michel BA; Villiger PM
J Rheumatol; 1997 Jan; 24(1):128-32. PubMed ID: 9002023
[TBL] [Abstract][Full Text] [Related]
19. Lymphokines and the acute-phase response in clinical bone marrow transplantation.
Cohen J; Bayston K
Eur Cytokine Netw; 1990; 1(4):251-5. PubMed ID: 1716489
[TBL] [Abstract][Full Text] [Related]
20. A possible association between the presence of interleukin-4-secreting cells and a reduction in the risk of acute graft-versus-host disease.
Takabayashi M; Kanamori H; Takasaki H; Yamaji S; Koharazawa H; Taguchi J; Tomita N; Fujimaki K; Fujisawa S; Maruta A; Ishigatsubo Y
Exp Hematol; 2005 Feb; 33(2):251-7. PubMed ID: 15676220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
